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Abstract
Background: Experimental analyses have identified strain-dependent factors that regulate susceptibility to
anaphylaxis in mice. We assessed the susceptibility of the widely used 129SvEvBrd (also known as 129S5) mouse
strain to IgE/mast cell-mediated anaphylaxis as compared to BALB/c. Mice were subjected to passive and oral
Ovalbumin [OVA]-induced active anaphylaxis. Tissue mast cell, plasma histamine, total IgE and OVA-specific IgE
levels and susceptibility to histamine i.v infusion were assessed. Bone marrow mast cell (BMMC)s were examined
for FcεRI, c-kit, degranulation efficiency, proliferation, apoptosis and cytokine profile.
Results: 129S5 mice had significantly increased susceptibility to passive and oral OVA-induced active anaphylaxis.
Increased susceptibility to anaphylaxis was associated with increased homeostatic mast cell levels but not OVA-
specific IgE or IgG1 levels. In vitro analyses of BMMCs revealed no difference in FcεRI and c-Kit expression, however,
129S5 BMMCs possessed greater proliferative capacity and reduced caspase-3-mediated apoptosis. IgE-BMMC
degranulation assays demonstrated no difference in degranulation efficiency. Furthermore, 129S5 mice possessed
increased sensitivity to histamine-induced hypothermia.
Conclusions: We conclude that 129S5 mice have increased susceptibility to anaphylaxis as compared to BALB/c
strain and their increased susceptibility was associated with altered mast cell proliferation and homeostatic tissue
levels and responsiveness to histamine. Given the wide spread usage of the 129SvEvBrd strain of mice in
experimental gene targeting methodology, these data have important implications for studying IgE-reactions in
mouse systems.
Background
Anaphylaxis is a rapid, life threatening allergic reaction
often triggered by food, drugs, insect venoms, latex, or
allergen immunotherapy [1-5]. Early clinical and experi-
mental evidence suggests that systemic anaphylaxis is
mediated by IgE/mast cell degranulation and the rapid
release of preformed mediators, including histamine,
proteoglycans, PAF, serotonin, tryptase, chymase and
lipid-derived mediators (PGD2 and LTC4, LTD4 and
LTE4) [6,7]. These mediators are reportedly acting on
target cells to induce vasodilation, increased vascular
permeability, hypotension, bronchospasm and, as a
result, shock.
With the recent emergence of several gene knockout
mice (FcЄRI, histamine decarboxylase, IL-4Ra) there has
been significant focus on employment of animal models
of IgE-mediated passive and active systemic and oral
antigen-induced anaphylaxis in an attempt to decipher
the relative contributions of inflammatory cells and
cytokines to disease pathogenesis [6,8]. These analyses,
while identifying important roles for specific molecules
in IgE-mast cell mediated reactions, have identified
strain-dependent factors that can influence mast cell
responses [9]. Moreover, IgE-activation of bone marrow-
derived mast cells (BMMCs) derived from C57BL/6 and
BALB/c mice promotes the release of different pre-
formed and newly synthesized mediators [10]. Further-
more, differences in susceptibility to food allergy in
C3H/HeJ and BALB/c mice were associated with differ-
ential Th2 - Th1 responses [11].
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widely utilized 129SvEvBrd (also known as 129S5) mice to
IgE-mediated passive anaphylaxis and oral OVA-induced
active anaphylaxis. We demonstrated increased suscept-
ibility to IgE-mast cell-mediated anaphylaxis in the 129S5
mice compared with BALB/c mice. We showed that sus-
ceptibility was associated with increased mast cell prolif-
erative capacity, homeostatic tissue mast cell levels and
responsiveness to histamine. Given the wide spread usage
of embryonic stem cells from the 129S5 strain of mice for
generation of various gene knockout mice [12-17] these
data have important implications for studying IgE-mast
cell reactions in mouse systems.
Methods
Animals
6-8 week old weight- and sex-matched 129SvEvBrd mice
(Lexicon Genetics, The Woodlands, Texas, USA ) and
BALB/c (originally provided by The Jackson Laboratory,
Bar Harbor, Maine, USA) mice were maintained in a
barrier facility, and animals were handled under
IACUC-approved protocols from Cincinnati Children’s
Hospital Medical Center.
Passive anaphylaxis model
IgE-mediated anaphylaxis was induced by intravenous
(i.v.) injection of rat IgG2a anti-mouse IgE mAb (rat
IgG2a, clone: EM-95) (10 μg/200 μl saline) and IgG
mediated anaphylaxis was induced by intravenous injec-
tion of rat IgG2b anti-mouse FcgRII/III mAb (rat IgG2b,
clone: 2.4G2) (500 μg/200 μl saline) as we have previously
described [18]. Rectal temperature was monitored for
60 minutes with a rectal probe (Physitemp Model BAT-
12) as previously described [18]. Concentration of anti-
mouse IgE and anti- mouse FcgRII/III mAb used were
determined in preliminary dose-response experiments
and also as we have previously demonstrated [19,20].
Experimental oral antigen-induced active anaphylaxis
6-8 week old mice were sensitized subcutaneously with
50 μg of ovalbumin [OVA] (Sigma-Aldrich, St. Louis,
MO) in the presence of 2 mg of aluminum potassium
sulfate adjuvant [alum: AIK(SO4)2-12H2O] (Sigma-
Aldrich, St.Louis, USA) in sterile saline. Two weeks
later, mice were deprived of food for 4 hours and
received intragastric (i.g) challenge of ovalbumin [OVA]
(50 mg/250 μl saline) employing i.g. feeding needles
(Fisher Scientific Co., Pittsburgh, Pennsylvania, USA).
Rectal temperatures and diarrhea were monitored at 30
and 60 minutes as we have previously described [18].
Effect of anti-histamine treatment
To assess the effect of anti-histamine treatment on oral
OVA-induced active anaphylaxis, 30 minutes prior to
the OVA challenge, mice were i.p injected with H1 and
H2 receptor antagonists 0.2 mg of Triprolidine and
0.2 mg of Cimetidine in 200 μl saline and subsequently
received OVA via oral gavage, after which rectal tem-
perature was monitored at 30 minutes and 60 minutes
time points as we have previously described [18].
Histamine-induced hypothermia
Histamine biphosphate monohydrate (Sigma-Aldrich, St.
Louis, USA) (25 μg/ml saline per mouse) was i.v
injected and body temperature was monitored by rectal
thermometry every 10 minutes for 60 minutes as we
have previously described [18].
Mast cell quantification
Ear, tongue and jejunum (7 - 10 cm distal to the sto-
mach) were collected and fixed in 10% formalin and
processed by standard histological techniques. Longitu-
dinal sections (5 μm) were stained for mast cells with
chloroacetate esterase (CAE) activity, as described pre-
viously [18]. At least four random sections per mouse
were analyzed. Quantification of stained cells was per-
formed by counting the number of chloroacetate-posi-
tive cells in 5 fields for tongue, 10 fields for ear and 20
fields for intestine (magnification 400 X).
BMMC generation
Bone marrow-derived cells (BMMCs) isolated from
6-8 week old mice were maintained in complete med-
ium consisting of RPMI 1640 supplemented with 10%
fetal bovine serum (Invitrogen, Carlsbad, USA), gluta-
mine (2 mM), penicillin (100 U/ml), streptomycin
(100 mg/ml), pyruvate (1 mM), nonessential amino
acids, hepes (10 mM), and 2-ME (50 μM) [21]. BMMCs
were cultured in the presence of IL-3 (20 ng/ml) (Pepro-
tech, Inc. Rocky Hill, USA) for the first three weeks, and
with both IL-3 (20 ng/ml) and SCF (10 ng/ml) (Pepro-
t e c h ,I n c .R o c k yH i l l ,U S A )d u r i n gw e e k4 .A f t e rf o u r
weeks of culture, BMMCs were examined for FcεRI, and
c-Kit expressions by flow cytometry analyses as we have
previously demonstrated [18,21] and were found to be
double positive (95-97%) for FcεRI and c-Kit at this time
point. 4-8 weeks old BMMCs were used for all
experiments.
Peritoneal mast cell analyses
Mice were anesthetized and a hypodermic needle were
inserted into the abdominal cavity (18 gauge). Sterile
saline (5 ml) was injected through a needle placed near
the sternum and the abdominal cavity was gently mas-
saged for 1 minute and the fluid removed. The perito-
neal lavage was centrifuged at 1200 rpm for 5 minutes
at room temperature. The supernatant was poured off
and the cell pellet resuspended in FACS buffer (PBS/1%
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FACS buffer (PBS/1% FCS) and incubated with combi-
nations of the following Abs: PE anti-mouse-FcεRI
(clone R35-72; 0.5 μg/10
6 cells; BD Pharmingen; San
J o s e ,C A ) ,F I T Ca n t i - m o u s eF c gRII/III (clone 2.4G2;
0.2 μg/10
6 cells; BD Pharmingen; San Jose, CA), APC-
Alexafluor-750 anti-mouse CD117 (c-kit) (0.2 μg/10
6
Ebioscience; San Diego, CA). The following Abs were
used as appropriate isotype controls: FITC rat IgG2a
and APC-AlexaFluor 750 rat IgG2a (BD Pharmingen;
San Jose, CA). Cells were analyzed on FACSCalibur (BD
Immunocytometry Systems; San Jose, CA), and analysis
was performed using Flow Jo software (Tree Star; Ash-
land, OR).
Degranulation Assay
BMMC degranulation was measured by hexosaminidase
release as described previously [22]. BMMCs (5 × 10
5
cells each) were sensitized with IgE anti-TNP mAb
(10 μg/ml) (BD Biosciences, San Jose, CA) for 2 hours.
Sensitized BMMCs in 100 μl suspension were chal-
lenged with BSA-TNP (10, 100 or 1000 ng/ml)
(Biosource Technologies, USA) in different concentra-
tions for 15 minutes. Supernatant was examined for
hexosaminidase activity by colormetric determination
using 4-Nitrophenyl N-acetyl-b-D-glucosaminide, PNAD
(Sigma, St.Louis, USA) at 405 nm. Degranulation is
expressed as the percentage of total hexosaminidase
activity. The BMMC lysate was used to estimate total
hexosaminidase activity. In some experiments BMMCs
(5 × 10
6/ml) were sensitized with IgE anti-TNP mAb
(10 μg/ml) for an hour, and challenged with BSA-TNP
(100 ng/ml) for 3 hours. Supernatant was analyzed for
IL-6, IL-13 and TNF-a by ELISA as described by manu-
facturer (R&D systems, Minneapolis, USA).
Proliferation Assay
BMMCs (2 × 10
6) were stained with CFSE (5 μM) (Invi-
trogen, Carlsbad, USA) for 10 min in PBS with 0.1%
BSA and cultured in the presence of IL-3 (20 ng/ml)
and SCF (10 ng/ml). The cells were examined by flow
cytometry for CFSE mean fluorescence intensity on the
4
th and 8
th day. CFSE positive cells were analyzed with a
proliferation software tool (Flowjo, Ashland, USA) [23].
Apoptosis
Apoptosis was determined using annexin V-allophyco-
cyanin and 7-aminoactinomycin D (7AAD), as we have
previously described [24]. Early apoptosis was defined as
annexin V-positive, 7AAD negative. Briefly, BMMCs
(2 × 10
6) were washed and resuspended in annexin
V-binding buffer and stained with annexin V-allophyco-
cyanin and 7AAD. Samples were then incubated at
room temperature for 15 minutes and analyzed by flow
cytoemetry. Active Caspase 3 expression, a biomarker
for cells in apoptosis, was examined by flow cytometry
using PE-Rabbit Anti-Active Caspase 3 antibody (BD
Pharmingen, San Diego, USA [24].
ELISA measurements
ELISA measurements for OVA-specific IgG1 and IgE
were done as previously reported [18]. Total IgE was
estimated as described by the manufacturer using a
mouse IgE Elisa Kit BD-Opt EIA™ (BD Biosciences,
New Jersey, USA). Total IgG1 and IgG2a concentrations
(1/10000) were compared between BALB/c and 129S5
mice. Serum IgG was captured with goat anti-mouse
IgG (1:1000 Dilution) (Southern Biotech, Birmingham,
USA). After capture, serum IgG1 and IgG2a were
detected by using different secondary antibodies; namely
goat anti-mouse IgG1-HRP (Southern Biotech, Birming-
h a m ,U S A )a n dg o a ta n t i - m o u s eI g G 2a-HRP (Southern
Biotech, Birmingham, USA), respectively.
Plasma Histamine determinations
Plasma was collected 5 min after anti-IgE-induced pas-
sive anaphylaxis (10 μg/200 μl saline i.v). Plasma was
collected in EDTA-coated tubes and plasma histamine
levels were determined with an histamine immunoassay
kit (Immunotech, Marseille Cedex, France) as described
by the manufacturer.
Statistical Analysis
Data are expressed as mean ± standard error of the
mean (SEM), unless otherwise stated. Statistical signifi-
cance comparing different sets of mice was determined
by Student’s t-test. In experiments comparing multiple
experimental groups, statistical differences between
groups were analyzed using the one-way ANOVA para-
metric and a Tukey’s multiple comparison post-test. In
experiments comparing two experimental groups, statis-
tical differences between groups were determined using
a Students T-test. P < 0.05 was considered significant.
All analyses were performed using Prism 5.0 software.
Results
Increased susceptibility of 129S5 mice to IgE/mast cell-
mediated anaphylaxis
Recently we and others have performed experimental
analyses employing murine models of anaphylaxis and
mice deficient in specific genes implicated in the regula-
tion of IgE and mast cell function to identify the relative
contribution of these molecules to the manifestations of
IgE/mast cell-mediated anaphylaxis [15,19,25-32]. These
analyses often involve usage of mice of different or
mixed strains, in particularly 129S5, a mouse strain fre-
quently used in gene targeting analyses, and the BALB/
c, a “Th2-skewed” strain that develop robust allergic
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sence of strain-dependent anaphylactic phenotypes
between these commonly utilized mouse strains to elim-
inate possible contribution of strain-dependent factors
in studies employing gene targeted mice. To assess this,
we initially examined passive IgE-mediated anaphylaxis
in 129S5 and BALB/c mice. Intravenous (i.v.) infusion of
anti-mouse IgE (EM95) resulted in anaphylaxis as evi-
denced by hypothermia (Figure 1). Notably, hypothermia
was significantly more severe in the 129S5 mice com-
pared to BALB/c (Figure 1a and 1b). To ascertain
whether the increased hypothermia was associated with
increased mast cell degranulation, we examined plasma
histamine levels. Notably, we found significantly elevated
plasma histamine levels in 129S5 mice compared to
BALB/c (Figure 1c). Importantly, 129S5 mice were not
significantly more susceptible to IgG mediated anaphy-
laxis (Figure 1d and 1e) indicating that this phenotype is
specific to IgE/mast cell-mediated reactions. We have
previously demonstrated that oral antigen triggered ana-
phylaxis is mast cell and IgE dependent [18,27]. To
assess whether 129S5 mice had increased susceptibility
to oral antigen triggered anaphylaxis, OVA-primed
129S5 and BALB/c mice were orally gavaged with
OVA and body temperature measured; notably,
hypothermia in the 129S5 mice was more severe than
that observed in BALB/c mice (Figure 2a). To deter-
mine whether oral OVA-triggered hypothermia was
histamine-dependent, mice received histamine receptor
type-1 and -2 receptor antagonists (Triprolidine and
Cimetidine) 30 minutes prior to the OVA challenge.
H1 and H2 receptor antagonism blocked the OVA-
induced hypothermia in both 129S5 and in BALB/c
mice indicating that anaphylaxis was mast cell/hista-
mine dependent (Figure 2b). To assess whether the
increased susceptibility to IgE-reactions in 129S5 mice
was due to increased sensitivity to mast cell mediators,
mice were i.v. injected with histamine and hypother-
mia was assessed. Injection (i.v) of histamine induced
a significant temperature decrease in both 129S5 mice
and BALB/c mice, however the decrease in 129S5
mice was significantly greater compared to that in
BALB/c mice (Figure 3a and 3b). These studies indi-
cated that 129S5 mice have increased susceptibility to
IgE/mast cell/histamine-mediated hypothermia relative
to BALB/c mice.
Figure 1 IgE and IgG passive anaphylaxis in 129S5 and BALB/c mice. a) Rectal temperature 0-60 minutes and (b) maximal temperature
change at 30 minutes and (c) Plasma histamine concentration at 5 minutes in control Ig and anti-IgE-treated (10 μg/200 μl saline) 129S5- and
BALB/c mice. d) Rectal temperature 0-60 minutes and (e) maximal temperature change at 30 minutes in control Ig and anti-FcgRII/III-treated (500
μg/200 μl saline) 129S5 and BALB/c mice. (n = 6) Data represent mean ± SEM. Data were analyzed by one-way analysis of variance (ANOVA) and
a post-hoc comparison test (Tukey-Kramer). (a) Triple asterisks indicate a P value < 0.001 compared with BALB/c + Anti-IgE. (b, c and e) Single
asterisk indicates a P value < 0.05. n.s. not significant.
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To determine whether the increased susceptibility was
associated with differences in total or antigen specific
IgE levels, we assessed serum immunoglobulin levels.
The total IgE, IgG1 and IgG2a levels were comparable
between naïve 129S5 and BALB/c mice (Figure 4a-c).
Furthermore, i.p. OVA/alum sensitization induced a
comparable OVA-specific serum IgE and IgG1 responses
(Figure 4d and 4e). We next assessed homeostatic tissue
mast cell levels, and demonstrated significantly elevated
mast cell levels in the ear and tongue, but not the intes-
tine, of the 129S5 mice compared to BALB/c mice
(Figure 5a-c). The data indicate that the increased sus-
ceptibility is associated with increased tissue mast cell
levels.
BMMC in 129S5 mice
To define if the divergence in susceptibility to anaphy-
laxis in 129S5 and BALB/c mice was due to inherent dif-
ferences in mast cell function, we assessed phenotypic
and degranulation properties of BMMCs. Surface expres-
sion of FcЄRI and c-Kit on BMMCs from 129S5 and
BALB/c mice were comparable (results not shown). Simi-
larly, the level of IgE-mediated degranulation of BMMCs,
as measured by b-hexosaminidase activity and cytokine
(IL-6, IL-13 and TNFa) release, was also not significantly
different between strains (Figure 6a and results not
shown). Since we observed increased systemic mast cell
levels in 129S5 compared to BALB/c mice, we examined
BMMC proliferation rate and apoptosis. Proliferation by
129S5 BMMCs in the presence of IL-3 and SCF was sig-
nificantly increased relative to BALB/c BMMC (Figure
7a). Furthermore, the level of 129S5 BMMC apoptosis
was reduced compared to BALB/c. Specifically, the per-
centage of BMMCs entering early apoptosis (Annexin V
+
7AAD
-) was significantly reduced in 129S5 BMMCs
compared to BALB/c (Figure.7b). Consistent with this
observation, active Caspase-3 expression was significantly
decreased in 129S5 BMMCs when compared to BALB/c
BMMCs (Figure 7c).
Discussion
129S5 mice demonstrated increased susceptibility to
both passive and active IgE-mediated anaphylaxis.
The increased susceptibility was linked with elevated
homeostatic tissue mast cells and increased sensitivity to
histamine infusion. In vitro analysis demonstrated
129S5-derived BMMCs have increased proliferative
capacity and decreased apoptosis. Collectively, these stu-
dies demonstrate that 129S5 mice have inherent differ-
ences in bone marrow-derived mast cell functional
capacity and sensitivity to mast cell-derived mediators,
and that these factors are sufficient to alter susceptibility
to IgE mediated anaphylactic reactions.
Systemic and oral antigen-induced IgE-mediated ana-
phylaxis in mice is dependent on the IgE-FcεRI-mast
cell pathway. Ag-IgE crosslinking of the FcεRI on mast
cells leads to degranulation and release of preformed
mediators, such as histamine, leading to anaphylactic
Figure 2 Oral antigen-induced anaphylaxis in 129S5 and BALB/
c mice is histamine-dependent. (a) Maximal rectal temperature
change at 30 minutes following OVA gavage of OVA-sensitized
129S5 and BALB/c mice. (b) Maximal rectal temperature change at
30 minutes following OVA gavage of OVA-sensitized 129S5 and
BALB/c mice treated with H1 and H2-receptor antagonists. Mice
were sensitized with OVA/Alum (50 μg/2 mg) subcutaneously. Two
weeks later, after 4 hours starvation, mice received oral gavage of
OVA (50 mg/250 μl) saline and rectal temperatures were recorded
at 30 and 60 minutes using rectal thermometry. b) Mice were i.p
injected with anti-histamine (0.2 mg Triprolidine + 0.2 mg
Cimetidine/200 μl saline) 30 minutes before prior to OVA- challenge
and rectal temperatures determined at 30 min and 60 minutes
following OVA gavage. (n = 8) Data represent mean ± SEM. Data
were analyzed by one-way analysis of variance (ANOVA) and a post-
hoc comparison test (Tukey-Kramer). Single and triple asterisks
indicate a P value less than < 0.01 and < 0.001, respectively.
Figure 3 Histamine-induces enhanced hypothermia in 129S5
mice. a) Rectal temperature 0-60 minutes and (b). Maximal rectal
temperature change at 30 minutes following i.v. injection of
histamine (5 mg/200 μl saline). Data presented as means ± SEM (n
= 6-8) and is representative of two separate experiments. Data were
analyzed by one-way analysis of variance (ANOVA) and a post-hoc
comparison test (Tukey-Kramer). (a) Single and double asterisks
indicate a P value < 0.05 and < 0.01 compared with BALB/c +
histamine. (b) Single asterisk indicate a P value less than < 0.05.
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antagonism of histamine activity blocked the anaphylac-
tic response. Notably, 129S5 mice have increased sus-
ceptibility to IgE-mediated anaphylaxis that is linked
with elevated systemic mast cells levels. We suggest that
activation of a greater number of mast cells leads to
increased systemic levels of mast cell mediators, such as
histamine, and increase severity of the anaphylactic reac-
tion. Consistent with this, we demonstrated increased
serum histamine in 129S5 mice compared to BALB/c.
Elevated serum histamine can also be attributed to
increased degranulation efficiency of mast cells, but we
found no difference in degranulation efficiency (i.e.
equivalent hexosaminidase and cytokine release) of
B M M C sf r o m1 2 9 S 5a n dB A L B / cm i c es u g g e s t i n gt h a t
mast cell load may explain the observed differences
between strains. Consistent with this, previous experi-
mental studies employing IL-9 transgenic mice have
demonstrated that elevated systemic mast cell levels
increased IgE-induced mast cell mediator release and
severity of anaphylaxis [34].
Analyses of BMMC from 129S5 and BALB/c mice
revealed differences in mast cell function. Moreover,
129S5 BMMC possessed increased proliferative capacity
and reduced apoptosis. The increased proliferative capa-
city and survival of 129S5 BMMCs could explain the
increased systemic mast cell levels in 129S5 mice com-
pared with BALB/c.
We demonstrated that IgE-mediated anaphylaxis
is histamine-dependent. Furthermore, we showed
increased plasma histamine in 129S5 mice compared
with BALB/c mice. Histamine regulates body tempera-
ture by acting on hypothalamic histaminergic neurons
in the central nervous system[ 2 9 ]o ra l t e r n a t i v e l y ,a n d
more relevant to a rapid anaphylactic reaction, via
induction of vascular leak through dysregulation of
endothelial gap formation of the vascular wall [35,36].
Interestingly, 129S5 mice displayed increased suscept-
ibility to intravenous histamine-induced hypothermia,
suggesting a strain-dependent difference in vascular per-
meability. This is consistent with the previously reported
strain-dependent differences in pulmonary vascular per-
meability in response to ischemia [37]. Collectively, our
data indicate that strain-dependent differences in tissue
mast cell levels attributed to possible increased prolifera-
tion and apoptosis rates and in part an increase in hista-
mine sensitivity heighten 129S5 mice to IgE-mast cell-
mediated reactions.
Figure 4 Antigen-specific and total IgG and IgE levels in 129S5 and BALB/c mice. Total (a) IgG1, (b) IgG2a and (c) IgE in the serum of
naive BALB/c and 129S5 mice. (d) OVA-specific IgE (d) and IgG1 (e) in OVA-sensitized mice. Data represents mean ± SEM. ( n = 4-6) and is
representative of two separate experiments. n.s. not significant.
Figure 5 Increased systemic mast cells in 129S5 mice. Mast cells/hpf in: a) jejunum, (b) ear skin and (c) tongue of 129S5 and BALB/c mice.
Data represent mean ± SEM (n = 4-6) and is representative of two separate experiments. Data were analyzed using a Students T-test. Single and
double asterisks indicate a P value < 0.05 and < 0.01 respectively. n.s. not significant.
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expression levels of the FcgRII can influence IgE-mast
cell regulated anaphylaxis [38,39]. Moreover, mice defi-
cient in the FcgRIIB display enhanced IgE-mediated
anaphylactic responses [38]. Notably, the 129/Sv and
129/Ola strains of mice share a promoter haplotype
associated with reduced expression and function of the
FcgRII [40]. To determine if the observed differences in
severity of anaphylaxis between 129S5 and BALB/c is
due to altered FcgR expression, we assessed FcgRII/III
expression on peritoneal mast cells [39]. We observed
no significant difference in expression of FcgRII/III on
129S5 peritoneal mast cells (c-kit
+ FceRI
+)c o m p a r e dt o
BALB/c (FcgRII/III mean fluoresence intensity [MFI]
61.9 ± 9.2 vs 74.4 ± 14.1; mean ±SD; n = 4 per group;
not significant) suggesting that the level of FcgRII/III on
mast cells is not the primary reason for the observed
differences in IgE-mast cell-triggered reactions. Impor-
tantly, Takai et al., [31] demonstrated that loss of FcgRII
expression was associated with increased IgE-and
IgG-triggered anaphylaxis. We did not observe any
significant differences in thes e v e r i t yo fI g G - m e d i a t e d
anaphylaxis between BALB/c and 129S5 mice further
supporting the notion that increased severity of anaphy-
laxis in 129S5 mice is independent of FcgRII expression.
Previous experimental data has identified strain-
dependent differences in mast cell function. Lyn
-/- mice
on the C57BL6 and BALB/c background demonstra-
ted opposite phenotypes with respect to mast cell
degranulation efficiency [9]. Furthermore, BALB/c
Figure 6 IgE-mediated BMMC degranulation in 129S5 and
BALB/c mice. (a) b-hexosaminidase activity at 15 minutes following
IgE-mediated degranulation of 129S5 and BALB/c BMMC. 4 week-
cultured 129S5 and BALB/c BMMCs (5 × 10
6/ml) were sensitized
with IgE-TNP (10 μg/ml) and challenged with BSA-TNP for 15
minutes and supernatant was assayed for hexosaminidase activity as
described in materials and methods. Data represents mean ± SEM
and is representative of three separate experiments. Data were
analyzed by one-way analysis of variance (ANOVA) and a post-hoc
comparison test (Tukey-Kramer). Double asterisks indicate a P value
< 0.01 compared with negative control (IgE and BSA-TNP negative).
Figure 7 Increased proliferation and decreased caspase-3-mediated apoptosis in 129S5 BMMC. (a) Representative flow cytometry plot
(day 8) of CFSE-labeled BALB/c and 129S5 BMMCs. Divisional index of 129S5 and BALB/c BMMCs cultured in IL3 (20ng/ml) and SCF (10ng/ml)
and CFSE-fluoresence decay was measured on day 4 and day 8 and analyzed by proliferation tool of Flowjo software to determine division
index. (b) Percentage of 7AAD- Annexin V
+ and (c) active caspase-3
+ 129S5 and BALB/c BMMCs (5-week old) cultured in IL-3 (20 ng/ml) and SCF
(10 ng/ml). Data represent mean ± SEM and is representative of three separate experiments. (a) Data were analyzed by one-way analysis of
variance (ANOVA) and a post-hoc comparison test (Tukey-Kramer). Single and double asterisks indicate a P value < 0.05 and < 0.01, respectively.
(b and c) data were analyzed using a Students T-test. Double and triple asterisks indicate a P value < 0.01 and < 0.001, respectively.
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are significantly elevated in comparison to C57BL6 [10].
We are unable to assess differences in vivo anaphylactic
phenotypes between 129S5, BALB/c and C57BL/6, as
C57BL/6 mice are resistant to oral antigen-induced ana-
phylaxis induced by OVA sensitization and repeated
oral challenge (results not shown). The fact that C57BL/
6 mice (H-2b haplotype) are resistant to oral antigen-
induced anaphylaxis, and the 129S5 (H-2b haplotype)
have increased responsiveness compared to BALB/c (H-
2d haplotype) indicates that severity of anaphylaxis in
these strains is independent of MHC haplotypes.
Furthermore, there are approximately 17 sub-strains in
the 129 strain, which possess quite different genetic and
phenotypic characteristics [41-43]. Thus, it is possible
that there are also differences in anaphylaxis phenotypes
between 129 substrains that are yet to be identified. Our
identification of substantial strain-dependent differences
between the mast cells of 129S5 and BALB/c mice has
important implications for the study of anaphylaxis and
mast cell biology given that embryonic stem cells from
129S5 mice are widely used in experimental gene target-
ing methodology [42-45]. The strain dependent differ-
ences indicate that rigorously designed breeding
strategies for control of genetic background must be
employed in such gene targeting studies to reduce the
influence of strain dependent traits on IgE-mast cell
responses in the knock out models.
Conclusions
In conclusion, higher systemic mast cell load and sensi-
tivity to histamine increases the susceptibility of 129S5
mouse strain to IgE-mast cell mediated anaphylaxis.
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